WPW
NVO

Warther Private Wealth’s Novo Nordisk NVO Stock Holding History

Warther Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$1.38M – 58
2025
Q2 		$1.38M Hold
20,000
– – 0.36% 20
2025
Q1 		$1.39M Buy
+20,000
New +$1.65M 0.46% 19

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Warther Private Wealth's NVO Position: Q1 2026 in Review

Warther Private Wealth increased its Novo Nordisk (NVO) stake by 24% in Q1 2026, buying an estimated $4.77M and bringing the position to 519,480 shares worth $19.1M. The position accounts for 4.48% of the portfolio, ranked #7.

Warther Private Wealth first reported a position in NVO in Q1 2024 and has held it in 9 quarters since. The position peaked at $26.1M in Q2 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Warther Private Wealth held 519,480 shares of Novo Nordisk worth $19.1M as of Q1 2026.
  • Warther Private Wealth bought 100,652 Novo Nordisk shares in Q1 2026, an estimated $4.77M.
  • Novo Nordisk made up 4.48% of Warther Private Wealth's portfolio in Q1 2026, its #7 holding.
  • Warther Private Wealth first reported a position in Novo Nordisk in Q1 2024 and has held it in 9 quarters since.
  • Warther Private Wealth's Novo Nordisk position peaked at $26.1M in Q2 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Warther Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.